Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure
Clinical trial NCT04442048 · COMPLETED
Trial details
- NCT number
- NCT04442048
- Sponsor
- Canadian Cancer Trials Group
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-01
- Primary completion
- 2024-05-07
- Enrollment
- 195
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.